MONACO , Oct. 29, 2025 (GLOBE NEWSWIRE) — AlphaPepe ($ALPE), a BNB Chain–based meme coin project, has reached a major presale milestone with over 3,000 early investors onboarded. The project reports consistent daily holder growth,… Read More »AlphaPepe Presale Reaches Major Milestone With Over 3,000 Early Investors Onboarded
Dubai, UAE, Oct. 29, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a rapidly emerging decentralized finance (DeFi) project built on Ethereum, has reached another key milestone, surpassing $18 million raised and growing its investor base… Read More »Mutuum Finance (MUTM) Nears Phase 6 Completion After Raising $18 Million and Building a 17,500+ Strong Investor Base
If you’re new to security cameras, I recommend PoE kits that are easy to install and deliver reliable high-res footage, like 4K systems with plug-and-play setup and weatherproof cameras. Look for kits with smart detection,… Read More »15 Best PoE Security Camera Kits for Beginners: Easy Setup and Reliable Security
TAIPEI, Oct. 29, 2025 /PRNewswire/ — Delta Electronics, Inc. (“Delta”), a leader in power management and smart green solutions, today announced the acquisition of 90.23% stake of Japan’s Noda RF Technologies Co., Ltd. (“NRF”)… Read More »Delta to Acquire Noda RF Technologies Co., Ltd. to Enhance its Power Solutions Portfolio for the Semiconductor Industry
Brands can now track, analyze and optimize their visibility across AI shopping agents like ChatGPT, Perplexity, and Gemini. SINGAPORE, CHICAGO and BERLIN, Oct. 29, 2025 /PRNewswire/ — AI shopping agents are reshaping how consumers discover and… Read More »Parcel Perform Defines ‘GEO’ for E-Commerce with Launch of AI Commerce Visibility
CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ — Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions to address trial complexity in mission-critical, time-sensitive moments, today announced… Read More »Suvoda launches unified patient app to reduce logistical challenges for clinical trial participants